Swiss stocks - Factors to watch on October 19

Novartis AG

Mon 05:54

ZURICH/GDANSK, Oct 19 (Reuters) - Here are some of the main factors that may affect Swiss stocks on Monday:

Norway, Switzerland, Iceland and Liechtenstein have signed a free-trade agreement with Vietnam, the governments of Norway and Vietnam announced on Sunday.
     
Rising public debt levels in Europe and beyond pose a risk to economic stability and could trigger a euro crisis, Swiss Finance Minister Karin Keller-Sutter said on Friday.
       
COMPANY STATEMENTS

ALCON AG ALCC.S 
FDA approves Alcon's Brytly Redness Reliever eye drops for up to 12 hours of whiter, brighter-looking eyes.

NOVARTIS NOVN.S 
Swiss drugmaker Novartis has terminated a mid-stage study testing its drug Fabhalta in patients with a serious kidney condition, citing "strategic considerations", according to a federal clinical trials registry.

ECONOMY
SNB sight deposits due at 0800 GMT.


 (Reporting by Zurich newsroom and Gdansk newsroom)
 ((+41 58 306 7336; zurich.newsroom@thomsonreuters.com))
For Top News in a multimedia Web format on Eikon visit: https://bit.ly/2NDFd6g

FOR RELATED PRICES, NEWS AND OTHER TOPICS, DOUBLE-CLICK ON:
Daily Swiss stock market report in German .SDE
All SMI constituent stocks 0#.SSMI
DJ STOXX index .STOXX
Top 10 STOXX sectors .PGL.STOXXS
Top 10 EUROSTOXX sectors .PGL.STOXXES

Swiss mid-cap index .SSMI
Swiss all-share index .SSHI
Swiss market digest .AD.S
Sector overview CH/SECTOR1
All Swiss news CH
Swiss research news CH-RCH  
All equity news E

SPEED GUIDES:  EQUITY, EQUITY/NEWS1, EUR/EQUITY, SWITZERLAND, REUTERS